Details for New Drug Application (NDA): 090108
✉ Email this page to a colleague
The generic ingredient in CLINDAMYCIN PHOSPHATE is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.
Summary for 090108
Tradename: | CLINDAMYCIN PHOSPHATE |
Applicant: | Sagent Pharms Inc |
Ingredient: | clindamycin phosphate |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Pharmacology for NDA: 090108
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 090108
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | INJECTABLE;INJECTION | 090108 | ANDA | Henry Schein, Inc. | 0404-9838 | 0404-9838-02 | 1 VIAL in 1 BAG (0404-9838-02) / 2 mL in 1 VIAL |
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | INJECTABLE;INJECTION | 090108 | ANDA | Henry Schein, Inc. | 0404-9838 | 0404-9838-04 | 1 VIAL in 1 BAG (0404-9838-04) / 4 mL in 1 VIAL |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | EQ 150MG BASE/ML | ||||
Approval Date: | Sep 30, 2011 | TE: | AP | RLD: | No |
Complete Access Available with Subscription